Semaglutide has rapidly emerged as one of the most transformative medications in the treatment of type 2 diabetes and obesity, with significant benefits for cardiovascular health. A member of the GLP-1 receptor agonist class, Semaglutide mimics the natural hormone glucagon-like peptide-1 (GLP-1) in the body, which plays a vital role https://keeganbkrzh.wikissl.com/1101911/semaglutide_a_breakthrough_in_managing_type_2_diabetes_obesity_and_heart_health